Fatty acid Metabolism Cont.
In the previous
post of Fatty acid metabolism, we talked about first part of oxidation of fatty
acids with even number of carbon atoms. SO, today we will talk about second
part of oxidation relating to odd number of carbon atoms of Fatty acids,
unsaturated fatty acids and ω-oxidation.
Fatty acid oxidation (odd number):
This process
proceeds by the same reaction steps as that of an even number of carbon atoms
until final 3 carbons are formed no 2 carbons as in even number. This
compound is called Propionyl CoA.
Propionyl CoA is metabolized on 3 pathways:
a) Propionyl CoA
is carboxylated into D- methylmalonyl CoA by propionyl CoA
carboxylase which requires coenzyme called
biotin.
b)
D-methylmalonyl CoA is converted into L-methylmalonyl CoA by methylmalonyl
CoA racemase.
c) Carbons of
L-methylmalonyl is rearranged forming succinyl CoA which enters TCA
cycle by enzyme methylmalonyl mutase which requires Coenzyme called Vitamin B12.
When there is deficiency
in vitamin B12, it leads to methylmalonic acidemia (Mutase is
missing or deficient) and aciduria (Patient is unable to convert vitamin
B12 into coenzyme).
Either type also
leads to metabolic acidosis and neurological manifestations.
As everyone knew
that beta oxidation of Fatty acids occurs in mitochondria, but there are some
exceptions for that:
1)
Very-long-chain- fatty acids (more than 22
carbon atoms) (VLCFAs) undergo their β-oxidation inside peroxisome as peroxisomes are the main site for synthetase enzyme that
activates this length of fatty acids.
The initial
dehydrogenation in peroxisome is catalyzed by FAD-containing
acyl CoA oxidase.
FADH2 produced is
oxidized by O2, which is reduced to H2O2. And No ATP is
generated in this step. H2O2 is reduced to H2O by catalase.
There are some genetic
defects that lead to:
a)
Inability to target matrix proteins (proteins
that form layer inside organelles) to peroxisomes resulting in Zellweger syndrome,
b)
Inability to transport VLCFAs across the peroxisomal
membrane resulting in X-linked adrenoleukodystrophy,
lead to accumulation of VLCFAs in the blood and tissues.
2)
α-oxidation of branched chain fatty acids like branched
chain of phytanic acid which is a product of chlorophyll
metabolism. this compound can't be substrate to acyl CoA
dehydrogenase due to methyl group on beta carbon.
Phytanic acid is
hydroxylated at the α-carbon by phytani
c CoA
alpha-hydroxylase (PhyH), so carbon 1
is released as CO2 and a product of 19 carbon atoms called Pristanal is formed which is oxidized into pristanic acid. And this acid is activated into
its CoA derivatives and completes β-oxidation steps.
There is a rare
disease occurring when there is deficiency in
PhyH which is called Refsum disease. This results in the
accumulation of phytanic acid in the plasma and tissues. The symptoms
are primarily neurologic, and the treatment involves dietary
restriction to halt disease progression.
c) ω-Oxidation which
generated diacylglycerol occurs in ER.
Oxidation of unsaturated
fatty acids:
It produces less
energy than that of saturated one because unsaturated fatty acids are less
reduced.
Oxidation of monounsaturated
fatty acids such as oleic acid requires one additional enzyme called 3,2 enoyl CoA isomerase to
convert the 3-cis derivative obtained after three rounds of β-oxidation to the 2-trans
derivative required as a substrate by the enoyl CoA hydratase.
Oxidation of polyunsaturated
fatty acids such as Linoleic acid requires NADH-dependent
2,4-dienoyl reductase + isomerase
Good job as always
ReplyDeleteThnx
Deleteعاش جداً يا شباب
ReplyDeleteThnx❤️
Delete